Literature DB >> 30926535

The first direct activity assay for the mitochondrial protease OMA1.

Julia Tobacyk1, Nirmala Parajuli1, Stephen Shrum1, John P Crow1, Lee Ann MacMillan-Crow2.   

Abstract

Mitochondria continually undergo fission and fusion which allow mitochondria to rapidly change their shape, size, and function throughout the cell life cycle. OMA1, a zinc metalloproteinase enzyme, is a key regulator of the mitochondrial fusion machinery. The paucity of information regarding OMA1 regulation and function largely stems from the fact that there is no direct method to quantitatively measure its activity. Using a fluorescence-based reporter assay, we developed a sensitive method to measure OMA1 enzymatic activity in whole cell lysates.
Copyright © 2019 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Keywords:  Fluorescence-based reporter; Fusion; Mitochondria; OMA1; Proteases

Mesh:

Substances:

Year:  2019        PMID: 30926535      PMCID: PMC6487223          DOI: 10.1016/j.mito.2019.03.001

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  28 in total

1.  Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis.

Authors:  Aurélien Olichon; Laurent Baricault; Nicole Gas; Emmanuelle Guillou; Annie Valette; Pascale Belenguer; Guy Lenaers
Journal:  J Biol Chem       Date:  2002-12-31       Impact factor: 5.157

2.  Oma1, a novel membrane-bound metallopeptidase in mitochondria with activities overlapping with the m-AAA protease.

Authors:  Michael Kaser; Melanie Kambacheld; Brigitte Kisters-Woike; Thomas Langer
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

3.  Selective Oma1 protease-mediated proteolysis of Cox1 subunit of cytochrome oxidase in assembly mutants.

Authors:  Oleh Khalimonchuk; Mi-Young Jeong; Talina Watts; Elliott Ferris; Dennis R Winge
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

Review 4.  Proteolytic control of mitochondrial function and morphogenesis.

Authors:  Ruchika Anand; Thomas Langer; Michael James Baker
Journal:  Biochim Biophys Acta       Date:  2012-06-27

Review 5.  Mitochondrial dynamics and disease, OPA1.

Authors:  Aurélien Olichon; Emmanuelle Guillou; Cécile Delettre; Thomas Landes; Laetitia Arnauné-Pelloquin; Laurent J Emorine; Valérie Mils; Marlène Daloyau; Christian Hamel; Patrizia Amati-Bonneau; Dominique Bonneau; Pascal Reynier; Guy Lenaers; Pascale Belenguer
Journal:  Biochim Biophys Acta       Date:  2006-04-20

Review 6.  Mitochondrial dynamics in cardiovascular health and disease.

Authors:  Sang-Bing Ong; Andrew R Hall; Derek J Hausenloy
Journal:  Antioxid Redox Signal       Date:  2012-09-10       Impact factor: 8.401

7.  Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice.

Authors:  Pedro M Quirós; Andrew J Ramsay; David Sala; Erika Fernández-Vizarra; Francisco Rodríguez; Juan R Peinado; Maria Soledad Fernández-García; José A Vega; José A Enríquez; Antonio Zorzano; Carlos López-Otín
Journal:  EMBO J       Date:  2012-03-20       Impact factor: 11.598

8.  Regulation of mitochondrial morphology through proteolytic cleavage of OPA1.

Authors:  Naotada Ishihara; Yuu Fujita; Toshihiko Oka; Katsuyoshi Mihara
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

9.  Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells.

Authors:  Brian Head; Lorena Griparic; Mandana Amiri; Shilpa Gandre-Babbe; Alexander M van der Bliek
Journal:  J Cell Biol       Date:  2009-12-28       Impact factor: 10.539

Review 10.  Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases.

Authors:  Hsiuchen Chen; David C Chan
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

View more
  2 in total

Review 1.  Recent advances in, and challenges of, designing OMA1 drug screens.

Authors:  Marcel V Alavi
Journal:  Pharmacol Res       Date:  2022-01-07       Impact factor: 7.658

2.  Does Disruption of Optic Atrophy-1 (OPA1) Contribute to Cell Death in HL-1 Cardiomyocytes Subjected to Lethal Ischemia-Reperfusion Injury?

Authors:  Andrew R Kulek; Vishnu V R Undyala; Anthony R Anzell; Sarita Raghunayakula; Lee Ann MacMillan-Crow; Thomas H Sanderson; Karin Przyklenk
Journal:  Cells       Date:  2022-09-30       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.